NEWS & EVENTS

Latest news and upcoming events

Memo Therapeutics increases Series C financing to CHF 45 million
07 May 2024

Memo Therapeutics increases Series C financing to CHF 45 million

Upcoming events

  • Bio€quity Europe
    14 - 16 May 2024,
    San Sebastián

    download

  • AseBio Investor Day 2024
    15 May 2024,
    San Sebastián

    download

  • ESMO Congress 2024
    13 - 19 September 2024,
    Barcelona

    download
02 Jun 2014

TiGenix completes the sale of its Dutch manufacturing facility to PharmaCell

Leuven, Belgium – 2 June, 2014 – TiGenix NV (Euronext Brussels: TIG), the European leader in cell therapy, announced today that it has completed the sale of its Dutch production facility to PharmaCell BV for a total consideration of Euro 5.75 million.
13 May 2014

TiGenix Business and Financial Update for the first quarter of 2014

Leuven, Belgium - 13 May, 2014 – TiGenix NV (Euronext Brussels: TIG), the European leader in cell therapy, issued today a business and financial update for the first three months of 2014.
09 May 2014

St. Jude Medical Announces TOCCASTAR Clinical Trial Meets Primary Safety and Efficacy Endpoints at Heart Rhythm 2014

ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced results of the TOCCASTAR clinical trial at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions in San Francisco.
23 Apr 2014

Kala Pharmaceuticals Announces $22.5 Million Series B Financing

Waltham, Mass., April 23, 2014 – Kala Pharmaceuticals, Inc., a leading developer of innovative ophthalmic products based on the company’s proprietary Mucus Penetrating Particle (MPP) platform technology, today announced it has completed a $22.5 million Series B financing.
03 Apr 2014

TiGenix licenses exclusive marketing and distribution rights for ChondroCelect to Sobi

Leuven (BELGIUM) – April 3, 2014 – TiGenix NV (Euronext Brussels: TIG), the European leader in cell therapy, announced today that it has licensed the marketing and distribution of ChondroCelect, the cell-based medicinal product for the repair of cartilage defects of the knee, to the international specialty healthcare company dedicated to rare diseases, Swedish Orphan Biovitrum AB (‘Sobi’, NASDAQ OMX Stockholm: SOBI).
26 Mar 2014

AM-Pharma announces positive Phase I data on recAP, for Acute Kidney Injury

Bunnik, The Netherlands, 26 March 2014. AM‐Pharma B.V., a biopharmaceutical company focused on the development of recAP (recombinant human Alkaline Phosphatase) for inflammatory indications, announces the results of its Phase I trial with both single and multiple ascending doses, which demonstrate that recAP is safe and well tolerated at all doses.
25 Mar 2014

MedLumics Announces “BiopsyPen Project” with €3.6M EU in Funding

MADRID--(BUSINESS WIRE)– MedLumics, a medical imaging company specializing in advanced optical coherence tomography (OCT) technology, today announced the kick off of a three-year initiative to translate the latest OCT research into new clinical applications.
Ysios Capital begins fundraising for Ysios Biofund II<
19 Mar 2014

Ysios Capital begins fundraising for Ysios Biofund II

New fund to back disruptive life sciences companies in Europe and US.
11 Mar 2014

TiGenix Reports Full Year 2013 Financial Results

Leuven (BELGIUM) – March 11, 2014 –TiGenix NV (Euronext Brussels: TIG), the European leader in cell therapy, gives an update of its business activities and announces financial results for the full year 2013.
04 Feb 2014

TiGenix reaches major cell therapy milestone with 1000th implant of ChondroCelect

Leuven (BELGIUM) – February 4, 2014 – TiGenix (NYSE Euronext: TIG), a leader in thefield of cell therapy, announced today that it reached a major milestone with the performance of the 1000th ChondroCelect implantation for cartilage repair in the knee.

Newsletter

subscribe

Subscribe to our weekly newsletter for the latest
updates on life sciences investments.

Bitplex 360 Кракен даркнет кракен даркнет Blacksprut Blacksprut Кракен ссылка кракен ссылка